Who Paid My Doc
Robert Mermer
Dentist, Oral and Maxillofacial Pathology Voorhees, NJ Doctor of Dentistry
NPI 1255372421 CMS profile 11848
1001 Laurel Oak Rd, Suite C1, Voorhees, NJ 08043
General payments
$990
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Robert Mermer of Voorhees, NJ is reported in the CMS Open Payments database as having received $990 across 17 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 70th percentile of Dentist, Oral and Maxillofacial Pathology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $16 | 1 | |
| 2022 | General | $100 | 1 | |
| 2021 | General | $48 | 2 | |
| 2020 | General | $697 | 9 | |
| 2019 | General | $130 | 4 |
Beside peers
- Robert Mermer
- Dentist, Oral and Maxillofacial Pathology median
- Middle half of Dentist, Oral and Maxillofacial Pathology
- National median
In program year 2025, general payments to Robert Mermer were reported at $0. Among 128 Dentist, Oral and Maxillofacial Pathology profiles paid that year, the median was $91 and the middle half received between $35 and $330.
Show as a table
| Year | Robert Mermer | Dentist, Oral and Maxillofacial Pathology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $130 | $106 | $28–$326 | $163 |
| 2020 | $697 | $109 | $33–$500 | $114 |
| 2021 | $48 | $104 | $30–$557 | $132 |
| 2022 | $100 | $104 | $37–$432 | $149 |
| 2023 | $16 | $152 | $41–$372 | $160 |
| 2024 | $0 | $100 | $38–$354 | $164 |
| 2025 | $0 | $91 | $35–$330 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 4 drugsPart D claims
96
Drug cost
$381
Branded share of claims
16.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 16 | $132 | |
| Chlorhexidine Gluconate | Generic | 28 | $107 | |
| Ibuprofen | Generic | 26 | $91 | |
| Amoxicillin | Generic | 26 | $51 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 110,731 Part D prescribers listed as Dentist; they describe a distribution and say nothing about conduct.
Records
17 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Oral and Maxillofacial Pathology in New Jersey
Vincent Carrao
Dentist, Oral and Maxillofacial Pathology · Fort Lee, NJ
Jesse Feuerstein
Dentist, Oral and Maxillofacial Pathology · Paterson, NJ
John Kallis
Dentist, Oral and Maxillofacial Pathology · Englewood Cliffs, NJ
Jessica Wollenberg
Dentist, Oral and Maxillofacial Pathology · Randolph, NJ
Stuart Meyer
Dentist, Oral and Maxillofacial Pathology · Ocean, NJ
Andrew Maron
Dentist, Oral and Maxillofacial Pathology · Union, NJ
Related records
Dentist, Oral and Maxillofacial Pathology in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Oral and Maxillofacial Pathology
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.